These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 18520988
1. Efficacy of levetiracetam in hemifacial spasm: a case report. Biagio Carrieri P, Petracca M, Montella S. Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988 [Abstract] [Full Text] [Related]
3. Efficacy of levetiracetam in primary hemifacial spasm. Kuroda T, Saito Y, Fujita K, Yano S, Ishigaki S, Kato H, Murakami H, Ono K. J Clin Neurosci; 2016 Dec; 34():213-215. PubMed ID: 27460515 [Abstract] [Full Text] [Related]
4. Levetiracetam in the treatment of idiopathic hemifacial spasm. Deleu D. Neurology; 2004 Jun 08; 62(11):2134-5. PubMed ID: 15184638 [No Abstract] [Full Text] [Related]
5. Levetiracetam for phasic spasticity in multiple sclerosis. Hawker K, Frohman E, Racke M. Arch Neurol; 2003 Dec 08; 60(12):1772-4. PubMed ID: 14676055 [Abstract] [Full Text] [Related]
6. Probable levetiracetam-associated depression in the elderly: two case reports. Vande Griend JP, Linnebur SA, Bainbridge JL. Am J Geriatr Pharmacother; 2009 Oct 08; 7(5):281-4. PubMed ID: 19948304 [Abstract] [Full Text] [Related]
8. Levetiracetam monotherapy in newly diagnosed cryptogenic West syndrome. Gümüş H, Kumandaş S, Per H. Pediatr Neurol; 2007 Nov 08; 37(5):350-3. PubMed ID: 17950421 [Abstract] [Full Text] [Related]
9. Efficacy of levetiracetam in Huntington disease. de Tommaso M, Di Fruscolo O, Sciruicchio V, Specchio N, Cormio C, De Caro MF, Livrea P. Clin Neuropharmacol; 2005 Nov 08; 28(6):280-4. PubMed ID: 16340384 [Abstract] [Full Text] [Related]
10. Treatment of tardive dyskinesia with levetiracetam in a transplant patient. Zivković SA, Costa G, Bond G, Abu-Elmagd KM. Acta Neurol Scand; 2008 May 08; 117(5):351-3. PubMed ID: 17995990 [Abstract] [Full Text] [Related]
11. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy. Specchio N, Boero G, Michelucci R, Gambardella A, Giallonardo AT, Fattouch J, Di Bonaventura C, de Palo A, Ladogana M, Lamberti P, Vigevano F, La Neve A, Specchio LM. Epilepsia; 2008 Apr 08; 49(4):663-9. PubMed ID: 18266754 [Abstract] [Full Text] [Related]
13. Rapid dosage titration of levetiracetam in children. Vaisleib II, Neft RA. Pharmacotherapy; 2008 Mar 08; 28(3):393-6. PubMed ID: 18294118 [Abstract] [Full Text] [Related]
14. Levetiracetam in tardive dyskinesia. Meco G, Fabrizio E, Epifanio A, Morgante F, Valente M, Vanacore N, Di Rosa AE, Morgante L. Clin Neuropharmacol; 2006 Mar 08; 29(5):265-8. PubMed ID: 16960471 [Abstract] [Full Text] [Related]
15. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age. Krief P, Li Kan, Maytal J. J Child Neurol; 2008 May 08; 23(5):582-4. PubMed ID: 18448575 [Abstract] [Full Text] [Related]
16. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox. Badarny S, Susel Z, Honigman S. Isr Med Assoc J; 2008 Jul 08; 10(7):520-2. PubMed ID: 18751631 [Abstract] [Full Text] [Related]
18. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study. Brighina F, Palermo A, Aloisio A, Francolini M, Giglia G, Fierro B. Clin Neuropharmacol; 2006 Jul 08; 29(6):338-42. PubMed ID: 17095897 [Abstract] [Full Text] [Related]
19. Levetiracetam prophylaxis in pediatric migraine--an open-label study. Pakalnis A, Kring D, Meier L. Headache; 2007 Mar 08; 47(3):427-30. PubMed ID: 17371359 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of levetiracetam in infants and young children with epilepsy. Glauser TA, Mitchell WG, Weinstock A, Bebin M, Chen D, Coupez R, Stockis A, Lu ZS. Epilepsia; 2007 Jun 08; 48(6):1117-22. PubMed ID: 17442002 [Abstract] [Full Text] [Related] Page: [Next] [New Search]